Ibrahim Osama Elnahal
Riyadh,Saudi Arabia
Summary
Experienced Medical Manager with the following key executive highlights:
Academic Background:
Clinical pharmacist with 2 MSc degrees in:
Advanced clinical Pharmacy Practice & Professional PharmD
Professional Background:
15 years in pharmaceutical field.
9 years in medical affairs
TA Background:
6 years in Oncology & Hematology
5 years in Diabetes & Metabolic
4 years in Immunology & Diversified
Geographical Background:
13 years for Saudi Arabia
2 years for GCC
2 years for Egypt
Official Assignments above role:
2 years Medical Regional Lead, MEAR "Middle East Africa & Russia"
1-year Medical Operation & Excellence lead for Saudi Arabia
Overview
17
17
years of professional experience
2025
2025
years of post-secondary education
Work history
Hematology / Oncology Medical Manager
AbbVie Biopharmaceuticals
Riyadh, Saudi Arabia
2023.10 - 2026.02
- Leading medical team for both Hematology and Oncology
- Setting medical affairs strategies, leading cross functional alignment, budgeting
- Experience in pre-launch and launch market preparations.
Immunology Medical Advisor
AbbVie Biopharmaceuticals
Riyadh
2022.02 - 2023.09
- Responsible for the whole kingdom
- Leading MSL personnel for Atopic Dermatitis “Assignment”
- Setting medical affairs strategies and projects for Atopic Dermatitis TA in alignment with brand team
- Clinical research experience (both interventional and observational)
Hematology Medical Advisor
AbbVie Biopharmaceuticals
Riyadh
2021.09 - 2022.01
- Responsible for the whole kingdom
- Setting/executing medical affairs strategies and projects for hematology TA in alignment with brand team.
Biotechnology Medical Advisor
Hikma Biotechnology
Riyadh
2019.06 - 2021.08
- Responsible for medical affairs strategies and projects across GCC for Biotechnology molecules with a focus on Oncology, Hematology and Immunology.
Oncology Medical Science Liaison
Merck Sharp & Dohme (MSD)
Riyadh
2018.05 - 2019.06
- Leading Immuno-oncology CDx. and medical projects across kingdom.
- Experience in pre-launch of different tumors indications.
Medical Science Liaison (Diversified TAs)
Merck Sharp & Dohme (MSD)
Riyadh
2016.03 - 2018.04
- Had the opportunity to work of several TAs including but not limited to cardiovascular, diabetes, respiratory and pain management.
Diabetes Product Specialist
Merck Sharp & Dohme (MSD)
Riyadh
2012.01 - 2016.02
- Responsible for promoting JANUVIA/JANUMET in institution /MOH sector (2015-2016)
- Responsible for promoting JANUVIA/JANUMET in private sector (2012-2015)
Product Specialist (Diabetes & Cardiovascular)
Bayer Schering
Cairo
2010.10 - 2011.12
- One of the team launched Xarelto (Rivaroxaban) in Egypt.
- Responsible for diabetes line (Acarbose)
Product Specialist (Diabetes & Cardiovascular)
Sigma Pharmaceuticals
Giza
2009.07 - 2010.09
- Diversified products including CVS.
Education
MSc of professional PharmD degree - PharmD (Pharmaceutical sciences)
Suez Canal University
IsmailiaMSc of Advanced Clinical Pharmacy Practice - Clinical Pharmacy
Queen's University
BelfastBachelor's degree - Pharmaceutical Science
Cairo University
CairoSkills
- Project Management
- Strategic thinking
- Decision Making
- Presentation/communication skills
- Emotional Intelligence
- Microsoft Office
- Multitasking
- Operations management
- Problem-solving abilities
- Adaptability and flexibility
Languages
Arabic - Native
English – Fluent
Accomplishments
- Medical Operations and Excellence Lead for Saudi Arabia - Above role assignment (AbbVie, 2025)
- Experience in managing/handling Audit inquiries (internal & external audits) (AbbVie, 2024-2025)
- Medical Regional Lead for MEAR "Middle East, Africa & Russia", (AbbVie) - Dermatology, 2023 & Oncology 2025
- Experience in handling SFDA medical inquires/drug Appeal throughout drug registration journey in alignment with different internal stakeholders like RA (AbbVie, 2024-2025)
- Experience in leading/executing regional medical events across MEAR "Middle East, Africa & Russia" (AbbVie, 2023-2025)
- Data generation for both interventional and observational studies; phase III and phase IV (MSD, AbbVie, 2018-2024)
- Reviewing and updating SOPs “Promotional and non-promotional materials review” (AbbVie, 2023)
- Veeva Vault champion (AbbVie, 2022-2023)
- MENA assignment for medical pre-launch readiness for Oncology portfolio in alignment with central marketing team (Hikma, 2021)
- Medical assessment for potential biotechnology molecules in alignment with business development team (Hikma, 2020)
- Co-author in a local study, DYSIS II Saudi Arabia with engaging 4 centers in the study – Published by SMJ ‘Saudi Medical Journal’ Saudi Med J. 2018 Jul;39(7):697-704. Doi: 10.15537/smj.2018.7.22146 Available online at: https://www.ncbi.nlm.nih.gov/pubmed/29968891 (MSD, 2018)
Personal Details
- Date of Birth: 28/09/1987
- Nationality: Egyptian
- Marital Status: Married
Timeline
Hematology / Oncology Medical Manager
AbbVie Biopharmaceuticals
2023.10 - 2026.02
Immunology Medical Advisor
AbbVie Biopharmaceuticals
2022.02 - 2023.09
Hematology Medical Advisor
AbbVie Biopharmaceuticals
2021.09 - 2022.01
Biotechnology Medical Advisor
Hikma Biotechnology
2019.06 - 2021.08
Oncology Medical Science Liaison
Merck Sharp & Dohme (MSD)
2018.05 - 2019.06
Medical Science Liaison (Diversified TAs)
Merck Sharp & Dohme (MSD)
2016.03 - 2018.04
Diabetes Product Specialist
Merck Sharp & Dohme (MSD)
2012.01 - 2016.02
Product Specialist (Diabetes & Cardiovascular)
Bayer Schering
2010.10 - 2011.12
Product Specialist (Diabetes & Cardiovascular)
Sigma Pharmaceuticals
2009.07 - 2010.09
MSc of Advanced Clinical Pharmacy Practice - Clinical Pharmacy
Queen's University
Bachelor's degree - Pharmaceutical Science
Cairo University
MSc of professional PharmD degree - PharmD (Pharmaceutical sciences)
Suez Canal University